Vergelijking

BPC-157 vs. TB-500

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Genezing

CAS-nr.

137525-51-0

geen gegevens

Molecuulmassa

1419.5 g/mol

888 g/mol

Halfwaardetijd

4 h

geen gegevens

Sequentie

GEPPPGKPADDAGLV

Ac-LKKTETQ

Werkingsmechanisme

BPC-157

Synthetic peptide derived from a sequence of a protein found in gastric juice. In preclinical models, an influence on angiogenic and tissue-protective signalling pathways has been described. The precise molecular mechanisms of action are not conclusively understood.

TB-500

Synthetic fragment of the endogenous protein Thymosin Beta-4. In preclinical models, an influence on cell migration, actin sequestration and neovascularisation has been described. Robust human pharmacokinetic data are not publicly available.

Bewijsbasis

Hoogste bewijs

Diermodel

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	BPC-157	TB-500
Australië	Verboden	Verboden
Zwitserland	Niet goedgekeurd	—
Duitsland	Niet goedgekeurd	Niet goedgekeurd
Verenigde Staten	Alleen onderzoek	Alleen onderzoek

Volledige vermeldingen

BPC-157

Volledige vermelding →

TB-500

Volledige vermelding →

Frequently asked questions

What is the difference between BPC-157 and TB-500?: BPC-157 is classified as "Genezing", while TB-500 is classified as "Genezing". BPC-157: Synthetic pentadecapeptide (15 amino acids) derived from a sequence of a gastric-juice protein. Studied predominantly in animal models on healing and protective processes — controlled human trials are rare and limited in scope. TB-500: Synthetic fragment of the endogenous protein Thymosin Beta-4, specifically the actin-binding sequence. Preclinical models investigate effects on cell migration, neovascularisation and wound healing — robust human data are absent. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, BPC-157 or TB-500?: The highest available evidence level is "Diermodel" for BPC-157 and "Diermodel" for TB-500. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of BPC-157 and TB-500 in Germany and the United States?: Duitsland: BPC-157 — Niet goedgekeurd, TB-500 — Niet goedgekeurd. Verenigde Staten: BPC-157 — Alleen onderzoek, TB-500 — Alleen onderzoek. These are factual summaries with source and review date on the individual pages.

Country

BPC-157

TB-500

Australië

Verboden

Zwitserland

Niet goedgekeurd

—

Duitsland

Niet goedgekeurd

Verenigde Staten

Alleen onderzoek

Frequently asked questions

What is the difference between BPC-157 and TB-500?

BPC-157 is classified as "Genezing", while TB-500 is classified as "Genezing". BPC-157: Synthetic pentadecapeptide (15 amino acids) derived from a sequence of a gastric-juice protein. Studied predominantly in animal models on healing and protective processes — controlled human trials are rare and limited in scope. TB-500: Synthetic fragment of the endogenous protein Thymosin Beta-4, specifically the actin-binding sequence. Preclinical models investigate effects on cell migration, neovascularisation and wound healing — robust human data are absent. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, BPC-157 or TB-500?

The highest available evidence level is "Diermodel" for BPC-157 and "Diermodel" for TB-500. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of BPC-157 and TB-500 in Germany and the United States?

Duitsland: BPC-157 — Niet goedgekeurd, TB-500 — Niet goedgekeurd. Verenigde Staten: BPC-157 — Alleen onderzoek, TB-500 — Alleen onderzoek. These are factual summaries with source and review date on the individual pages.